Modelling neurodegenerative diseases in Drosophila: A fruitful approach?

Nature Reviews Neuroscience

Volumn 3, Issue 3, 2002, Pages 237-243

  Muqit, Miratul M K ^a   Feany, Mel B ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DROSOPHILA MELANOGASTER; MELANOGASTER;

ALZHEIMER DISEASE; ANIMAL; DEGENERATIVE DISEASE; DISEASE MODEL; DROSOPHILA MELANOGASTER; GENETICS; HUMAN; METABOLISM; MUTATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; TRANSGENIC ANIMAL; TRINUCLEOTIDE REPEAT;

ALZHEIMER DISEASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; MUTATION; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0036514504     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn751     Document Type: Article

References (57)

1. Morgan, T. H. The Physical Basis of Heredity (J. B. Lippincott, Philadelphia, 1919).
2. Alzheimer, A. Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatr. Psych.-Gerichtl. Med. 64, 146-148 (1907).
3. Lewy, F. Zur pathologischen Anatomie der Paralysis agitans. Dtsch. Z. Nervenheilkd. 50, 50-55 (1913).
4. St Johnston, D. & Nusslein-Volhard, C. The origin of pattern and polarity in the Drosophila embryo. Cell 68, 201-219 (1992).
5. Adams, M. D. etal. The genome sequence of Drosophila melanogaster. Science 287, 2185-2195 (2000).
6. Brand, A. H. & Perrimon, N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415 (1993).
7. Polymeropoulos, M. H. et al. Mutation in the a-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047 (1997).
8. Kruger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet. 18, 106-108 (1998).
9. Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839-840 (1997).
10. Feany, M. B. & Bender, W. W. A Drosophila model of Parkinson's disease. Nature 404, 394-398 (2000).
11. Arriagada, P. V, Growden, J. H., Hedley-Whyte, T. & Hyman, B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639 (1992).
12. Hutton, M. et al. Association of missense and 5'-splice- site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705 (1998).
13. Wittmann, C. W. et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711-714 (2001).
14. Herreman, A. et al. Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells. Nature Cell Biol. 2, 461-462 (2000).
15. Esler, W. P. et al. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1. Nature Cell Biol. 2, 428-434 (2000).
16. Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706 (1991).
17. Hardy, J. The Alzheimer family of diseases: many aetiologies, one pathogenesis. Proc. Natl Acad. Sci. USA 94, 2095-2097 (1997).
18. Gunawardena, S. & Goldstein, L. S. B. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389-401 (2001).
19. Fossgreen, A. et al. Transgenic Drosophila expressing human amyloid precursor protein show γ-secretase activity and a blistered-wing phenotype. Proc. Natl Acad. Sci. USA 95, 13703-13708 (1998).
20. Struhl, G. & Greenwald, I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398, 522-525 (1999).
21. Ye, Y., Lukinova, N. & Fortini, M. E. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 398, 525-529 (1999).
22. Levitan, D. & Greenwald, I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354 (1995).
23. Struhl, G. & Greenwald, I. Presenilin-mediated transmembrane cleavage is required for Notch signal transduction in Drosophila. Proc. Natl Acad. Sci. USA 98, 229-234 (2001)
24. Joutel, A. et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707-710 (1996).
25. Cao, X. & Sudhof, T. A. Transcriptively active complex of APP with Fe65 and histone actyltransferase Tip60. Science 293, 115-120 (2001).
26. Gusella, J. F. & MacDonald, M. E. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nature Rev. Neurosci. 1, 109-115 (2000).
27. Marsh, J. L. et al. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet. 9, 13-25 (2000).
28. Zuccato, C. et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498 (2001).
29. Yuasa, T. et al. Joseph's disease: clinical and pathologic studies in a Japanese family. Ann. Neurol. 19, 152-157 (1986).
30. Ikeda, H. et al. Expanded polyglutamine in the Machado- Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13, 196-202 (1996).
31. Warrick, J. M. et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93, 939-949 (1998).
32. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983 (1993).
33. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993 (1997).
34. Jackson, G. R. et al. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633-642 (1998).
35. Steffan, J. S. et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739-743 (2001).
36. Fernandez-Funez, P. et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408, 101-106 (2000).
37. Warrick, J. M. et al. Suppression of polyglutamine- mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nature Genet. 23, 425-428 (1999).
38. Chan, H.Y.E., Warrick, J. M., Gay-Board, G.L., Paulson, H. L. & Bonini, N. M. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet. 9, 2811-2820 (2000).
39. Auluck, P K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V M.-Y & Bonini, N. M. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 20 December 2001 (doi:10.1126/science.1067389).
40. Kazemi-Esfarjani, P. & Benzer, S. Genetic suppression of polyglutamine toxicity in Drosophila. Science 287, 1837-1840 (2000).
41. McCampbell, A. et al. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9, 2197-2202 (2000).
42. Davidson, F. F. & Stellar, H. Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants. Nature 391, 587-591 (1998).
43. Lewis, J. et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491 (2001).
44. Gotz, J., Chen, J., Van Dorpe, J. & Nitsch, R. M. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Ap42 fibrils. Science 293, 1491-1495 (2001).
45. Elia, A. J. et al. Expression of human FALS SOD in motoneurons of Drosophila. Free Radic. Biol. Med. 26, 1332-1338 (1999).
46. Raeber, A. J., Muramoto, T., Kornberg, T. B. & Prusiner, S. B. Expression and targeting of Syrian hamster prion protein induced by heat shock in transgenic Drosophila melanogaster. Mech. Dev. 51, 317-327 (1995).
47. Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608 (1998).
48. Yamamoto, A., Lucas, J. J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57-66 (2000).
49. Osterwalder, T., Yoon, K. S., White, B. H. & Keshishian, H. A conditional tissue-specific transgene expression system using inducible GAL4. Proc. Natl Acad. Sci. USA 98, 12596-12601 (2001).
50. Stebbins, M. J. et al. Tetracycline-inducible systems for Drosophila. Proc. Natl Acad. Sci. USA 98, 10775-10780 (2001).
51. Min, K.-T. & Benzer, S. Preventing neurodegeneration in the Drosophila mutant bubblegum. Science 284, 1985-1988 (1999).
52. Van Geel, B. M. et al. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with 'Lorenzo's oil'. J. Neurol. Neurosurg. Psychiatry 67, 290-299 (1999).
53. Kretzschmar, D., Hasan, G., Sharma, S., Heisenberg, M. & Benzer, S. The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J. Neurosci. 17, 7425-7432 (1997).
54. Min, K. T. & Benzer, S. Spongecake and eggroll: two hereditary diseases in Drosophila resemble patterns of human brain degeneration. Curr. Biol. 7, 885-888 (1997).
55. Buchanan, R. L. & Benzer, S. Defective glia in the Drosophila brain degeneration mutant drop-dead. Neuron 10, 839-850 (1993).
56. Eberl, D. F., Duyk, G. M. & Perrimon, N. A genetic screen for mutations that disrupt an auditory response in Drosophila melanogaster. Proc. Natl Acad. Sci. USA 94, 14837-14842 (1997).
57. Bennett, C. L. & Chance, P. F. Molecular pathogenesis of hereditary motor, sensory and autonomic neuropathies. Curr. Opin. Neurol. 14, 621-627 (2001)